Equity Overview
Price & Market Data
Price: $0.178
Daily Change: $0.00 / 0.00%
Daily Range: $0.178 - $0.178
Market Cap: $23,666,480
Daily Volume: 30,000
Performance Metrics
1 Week: 6.40%
1 Month: 11.13%
3 Months: 1.02%
6 Months: 3.98%
1 Year: -46.59%
YTD: 1.20%
Details
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment, and diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.